This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/FHM865. CME credit will be available until March 9, 2026.
Navigating MOGAD: Case-Based Insights Into Diagnosis, Treatment, and Management of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from UCB, Inc.
Disclosure information is available at the beginning of the video presentation.
View all episodes
By PVI, PeerView Institute for Medical Education
4.3
1010 ratings
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/FHM865. CME credit will be available until March 9, 2026.
Navigating MOGAD: Case-Based Insights Into Diagnosis, Treatment, and Management of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from UCB, Inc.
Disclosure information is available at the beginning of the video presentation.
5 Listeners
3 Listeners
3 Listeners
5 Listeners
27 Listeners
10 Listeners
3 Listeners
2 Listeners
4 Listeners
3 Listeners
285 Listeners
3 Listeners
5 Listeners
5 Listeners
2 Listeners
130 Listeners
0 Listeners
9 Listeners
2 Listeners
15,039 Listeners
61 Listeners
10 Listeners
45 Listeners
2 Listeners
496 Listeners
111,165 Listeners
55,956 Listeners
1,081 Listeners
7,994 Listeners
286 Listeners
549 Listeners
12,630 Listeners
28,349 Listeners
112 Listeners